cached image

Gabriella Gobbi, MD PhD - Publications

Affiliations: 
Psychiatry McGill University, Montreal, QC, Canada 
Area:
Mental Illness and Addiction, Neurosciences
Website:
http://www.medicine.mcgill.ca/psychiatry/gobbi/Site_Gobbi_Lab/Welcome.html

86 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 De Gregorio D, Inserra A, Enns JP, Markopoulos A, Pileggi M, El Rahimy Y, Lopez-Canul M, Comai S, Gobbi G. Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 47: 1188-1198. PMID 35301424 DOI: 10.1038/s41386-022-01301-9  0.383
2021 De Gregorio D, Popic J, Enns JP, Inserra A, Skalecka A, Markopoulos A, Posa L, Lopez-Canul M, Qianzi H, Lafferty CK, Britt JP, Comai S, Aguilar-Valles A, Sonenberg N, Gobbi G. Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 33495318 DOI: 10.1073/pnas.2020705118  0.776
2020 De Gregorio D, Dean Conway J, Canul ML, Posa L, Bambico FR, Gobbi G. Effects of chronic exposure to low doses of Δ9- tetrahydrocannabinol in adolescence and adulthood on serotonin/norepinephrine neurotransmission and emotional behaviors. The International Journal of Neuropsychopharmacology. PMID 32725198 DOI: 10.1093/Ijnp/Pyaa058  0.77
2020 Posa L, Lopez-Canul M, Rullo L, De Gregorio D, Dominguez-Lopez S, Aboud MK, Felicia Caputi F, Candeletti S, Romualdi P, Gobbi G. Nociceptive responses in MT receptor knockout mice compared to MT and double MT /MT receptor knockout mice. Journal of Pineal Research. e12671. PMID 32430930 DOI: 10.1111/Jpi.12671  0.791
2020 Comai S, De Gregorio D, Posa L, Ochoa-Sanchez R, Bedini A, Gobbi G. Dysfunction of serotonergic activity and emotional responses across the light-dark cycle in mice lacking MT receptors. Journal of Pineal Research. e12653. PMID 32239546 DOI: 10.1111/Jpi.12653  0.789
2019 Bambico FR, Li Z, Creed M, De Gregorio D, Diwan M, Li J, McNeill S, Gobbi G, Raymond R, Nobrega JN. A Key Role for Prefrontocortical Small Conductance Calcium-Activated Potassium Channels in Stress Adaptation and Rapid Antidepressant Response. Cerebral Cortex (New York, N.Y. : 1991). PMID 31504265 DOI: 10.1093/Cercor/Bhz187  0.781
2019 López-Canul M, Min SH, Posa L, De Gregorio D, Bedini A, Spadoni G, Gobbi G, Comai S. Melatonin MT and MT Receptors Exhibit Distinct Effects in the Modulation of Body Temperature across the Light/Dark Cycle. International Journal of Molecular Sciences. 20. PMID 31108968 DOI: 10.3390/Ijms20102452  0.756
2019 Comai S, Lopez-Canul M, De Gregorio D, Posner A, Ettaoussi M, Guarnieri F, Gobbi G. Melatonin MT receptor as a novel target in neuropsychopharmacology: MT ligands, pathophysiological and therapeutic implications and perspectives. Pharmacological Research. PMID 31029764 DOI: 10.1016/J.Phrs.2019.04.015  0.45
2019 Gobbi G, Comai S. Differential Function of Melatonin MT and MT Receptors in REM and NREM Sleep. Frontiers in Endocrinology. 10: 87. PMID 30881340 DOI: 10.3389/Fendo.2019.00087  0.381
2019 Lopez-Canul M, Sasson T, Ochoa-Sanchez R, He Q, Yin S, De Gregorio D, Posa L, Comai S, Gobbi G. Effect of the selective melatonin MT1 receptor partial agonist UCM871 in the activity of noraphineprine neurons of the locus coeruleus during the sleep/wake cycle Sleep Medicine. 64: S231. DOI: 10.1016/J.Sleep.2019.11.646  0.761
2019 De Gregorio D, Popic J, Enns J, Posa L, Aguilar-Valles A, Sonenberg N, Gobbi G. S.17.02 Lysergic acid diethylamide reverses anxious-like behaviour and modulates serotonergic neurotransmission in a chronic stress model European Neuropsychopharmacology. 29: S12-S13. DOI: 10.1016/j.euroneuro.2019.09.042  0.714
2018 Gobbi G, Comai S. Sleep well. Untangling the role of melatonin MT1 and MT2 receptor in sleep. Journal of Pineal Research. e12544. PMID 30586215 DOI: 10.1111/Jpi.12544  0.385
2018 De Gregorio D, Enns JP, Nuñez NA, Posa L, Gobbi G. d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders. Progress in Brain Research. 242: 69-96. PMID 30471683 DOI: 10.1016/Bs.Pbr.2018.07.008  0.787
2018 De Gregorio D, Manchia M, Carpiniello B, Valtorta F, Nobile M, Gobbi G, Comai S. Role of palmitoylethanolamide (PEA) in depression: Translational evidence. Journal of Affective Disorders. PMID 30391203 DOI: 10.1016/J.Jad.2018.10.117  0.323
2018 De Gregorio D, McLaughlin RJ, Posa L, Ochoa-Sanchez R, Enns J, Lopez-Canul M, Aboud M, Maione S, Comai S, Gobbi G. Cannabidiol modulates serotonergic transmission and prevents allodynia and anxiety-like behavior in a model of neuropathic pain. Pain. PMID 30157131 DOI: 10.1097/J.Pain.0000000000001386  0.819
2018 Aguilar-Valles A, Haji N, De Gregorio D, Matta-Camacho E, Eslamizade MJ, Popic J, Sharma V, Cao R, Rummel C, Tanti A, Wiebe S, Nuñez N, Comai S, Nadon R, Luheshi G, ... ... Gobbi G, et al. Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E. Nature Communications. 9: 2459. PMID 29941989 DOI: 10.1038/S41467-018-04883-5  0.37
2018 Bambico FR, Comai S, Hasan MSN, Conway JD, Darvish-Gane S, Hamani C, Gobbi G, Nobrega JN. High frequency stimulation of the anterior vermis modulates behavioural response to chronic stress: Involvement of the prefrontal cortex and dorsal raphe? Neurobiology of Disease. PMID 29727711 DOI: 10.1016/J.Nbd.2018.03.011  0.763
2018 Messaoud A, Rym M, Douki W, Neffati F, Najjar MF, Gobbi G, Valtorta F, Gaha L, Comai S. Reduced peripheral availability of tryptophan and increased activation of the kynurenine pathway and cortisol correlate with major depression and suicide. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-28. PMID 29683396 DOI: 10.1080/15622975.2018.1468031  0.372
2018 Atkin T, Comai S, Gobbi G. Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery. Pharmacological Reviews. 70: 197-245. PMID 29487083 DOI: 10.1124/Pr.117.014381  0.326
2017 Atkin T, Nuñez N, Gobbi G. Practitioner review: The effects of atypical antipsychotics and mood stabilisers in the treatment of depressive symptoms in paediatric bipolar disorder. Journal of Child Psychology and Psychiatry, and Allied Disciplines. PMID 28474733 DOI: 10.1111/Jcpp.12735  0.302
2017 Posa L, De Gregorio D, Gobbi G, Comai S. Targeting melatonin MT2 receptors: A novel pharmacological avenue for inflammatory and neuropathic pain. Current Medicinal Chemistry. PMID 28183259 DOI: 10.2174/0929867324666170209104926  0.764
2017 Gobbi G, Lopez-Canul M, Ochoa-Sanchez R, Comai S. Anxiolytic, hypnotic and analgesic properties of melatonin MT2 receptor partial agonists European Neuropsychopharmacology. 27: S569-S570. DOI: 10.1016/S0924-977X(17)31099-4  0.403
2017 Comai S, Posa L, Ochoa-Sanchez R, Spadoni G, Gobbi G. Neuropsychopharmacological properties of novel melatonin MT1 receptor ligands European Neuropsychopharmacology. 27: S569. DOI: 10.1016/S0924-977X(17)31098-2  0.741
2017 De Gregorio D, Posa L, Ochoa-Sanchez R, McLaughlin R, Maione S, Comai S, Gobbi G. D-lysergic diethylamide modulates dopaminergic neurons of ventral tegmental area via 5-HT1A, D2 and TAAR1 receptors European Neuropsychopharmacology. 27: S53-S54. DOI: 10.1016/S0924-977X(17)30124-4  0.791
2016 De Gregorio D, Comai S, Posa L, Gobbi G. d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology. International Journal of Molecular Sciences. 17. PMID 27886063 DOI: 10.3390/Ijms17111953  0.775
2016 De Gregorio D, Posa L, Ochoa-Sanchez R, McLaughlin R, Maione S, Comai S, Gobbi G. The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors. Pharmacological Research. 113: 81-91. PMID 27544651 DOI: 10.1016/J.Phrs.2016.08.022  0.827
2016 Comai S, Bertazzo A, Vachon J, Daigle M, Toupin J, Côté G, Turecki G, Gobbi G. Tryptophan via serotonin/kynurenine pathways abnormalities in a large cohort of aggressive inmates: Markers for aggression. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 27117820 DOI: 10.1016/J.Pnpbp.2016.04.012  0.379
2016 Gobbi G, Lopez-Canul M, Palazzo E, Dominguez-Lopez S, Luongo L, Lacoste B, Comai S, Angeloni D, Fraschini F, Spadoni G, Bedini A, Tarzia G, Maione S, Granados-Soto V. PT628. First in class melatonin MT2 receptors agonists for neuropathic pain The International Journal of Neuropsychopharmacology. 19: 30-30. DOI: 10.1093/Ijnp/Pyw044.628  0.334
2016 Gregorio DD, Posa L, Ochoa-Sanchez R, McLaughlin R, Maione S, Comai S, Gobbi G. PM361. The hallucinogen D-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors The International Journal of Neuropsychopharmacology. 19: 32-32. DOI: 10.1093/Ijnp/Pyw041.361  0.782
2016 Morales-Medina JC, Juarez I, Dominguez-Lopez S, Kandimalla R, Gobbi G, Flores G, Quirion R. The Y2 receptor antagonist BIIE0246 reverses corticosterone-induced anxiogenic-related behavior and neuronal hypertrophy Neuropeptides. 55: 21. DOI: 10.1016/J.Npep.2015.11.058  0.428
2015 Bambico FR, Duranti A, Nobrega JN, Gobbi G. The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampus. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26747370 DOI: 10.1016/J.Euroneuro.2015.12.027  0.776
2015 López-Canul M, Comai S, Domínguez-López S, Granados-Soto V, Gobbi G. Antinociceptive properties of selective MT2 melatonin receptor partial agonists. European Journal of Pharmacology. 764: 424-32. PMID 26162699 DOI: 10.1016/J.Ejphar.2015.07.010  0.396
2015 Lacoste B, Angeloni D, Dominguez-Lopez S, Calderoni S, Mauro A, Fraschini F, Descarries L, Gobbi G. Anatomical and cellular localization of melatonin MT1 and MT2 receptors in the adult rat brain. Journal of Pineal Research. 58: 397-417. PMID 25726952 DOI: 10.1111/Jpi.12224  0.396
2015 Comai S, Ochoa-Sanchez R, Dominguez-Lopez S, Bambico FR, Gobbi G. Melancholic-Like behaviors and circadian neurobiological abnormalities in melatonin MT1 receptor knockout mice. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 18. PMID 25638817 DOI: 10.1093/Ijnp/Pyu075  0.767
2015 Lopez-Canul M, Palazzo E, Dominguez-Lopez S, Luongo L, Lacoste B, Comai S, Angeloni D, Fraschini F, Boccella S, Spadoni G, Bedini A, Tarzia G, Maione S, Granados-Soto V, Gobbi G. Selective melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathways. Pain. 156: 305-17. PMID 25599452 DOI: 10.1097/01.J.Pain.0000460311.71572.5F  0.446
2015 Bambico FR, Lacoste B, Hattan PR, Gobbi G. Father absence in the monogamous california mouse impairs social behavior and modifies dopamine and glutamate synapses in the medial prefrontal cortex. Cerebral Cortex (New York, N.Y. : 1991). 25: 1163-75. PMID 24304503 DOI: 10.1093/Cercor/Bht310  0.695
2014 Domínguez-López S, Howell RD, López-Canúl MG, Leyton M, Gobbi G. Electrophysiological characterization of dopamine neuronal activity in the ventral tegmental area across the light-dark cycle. Synapse (New York, N.Y.). 68: 454-67. PMID 24955825 DOI: 10.1002/Syn.21757  0.37
2014 Rainer Q, Speziali S, Rubino T, Dominguez-Lopez S, Bambico FR, Gobbi G, Parolaro D. Chronic nandrolone decanoate exposure during adolescence affects emotional behavior and monoaminergic neurotransmission in adulthood. Neuropharmacology. 83: 79-88. PMID 24721625 DOI: 10.1016/J.Neuropharm.2014.03.015  0.792
2014 Ochoa-Sanchez R, Comai S, Spadoni G, Bedini A, Tarzia G, Gobbi G. Melatonin, selective and non-selective MT1/MT2 receptors agonists: differential effects on the 24-h vigilance states. Neuroscience Letters. 561: 156-61. PMID 24406151 DOI: 10.1016/J.Neulet.2013.12.069  0.366
2014 Comai S, Gobbi G. Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology. Journal of Psychiatry & Neuroscience : Jpn. 39: 6-21. PMID 23971978 DOI: 10.1503/Jpn.130009  0.388
2014 Comai S, Ochoa-Sanchez R, Gobbi G. P.1.g.109 Distinct role of melatonin MT1 and MT2 receptors in sleep and anxiety: insights from melatonin receptor knockout mice European Neuropsychopharmacology. 24: S268. DOI: 10.1016/S0924-977X(14)70420-1  0.374
2014 Gobbi G, Comai S, Ochoa-Sanchez R. S.27.01 Novel selective melatonin MT2 receptor agonist in the treatment of insomnia European Neuropsychopharmacology. 24: S144. DOI: 10.1016/S0924-977X(14)70210-X  0.385
2013 Comai S, Ochoa-Sanchez R, Gobbi G. Sleep-wake characterization of double MT₁/MTâ‚‚ receptor knockout mice and comparison with MT₁ and MTâ‚‚ receptor knockout mice. Behavioural Brain Research. 243: 231-8. PMID 23333399 DOI: 10.1016/J.Bbr.2013.01.008  0.363
2012 Domínguez-López S, Howell R, Gobbi G. Characterization of serotonin neurotransmission in knockout mice: implications for major depression. Reviews in the Neurosciences. 23: 429-43. PMID 23089640 DOI: 10.1515/Revneuro-2012-0044  0.453
2012 Ochoa-Sanchez R, Rainer Q, Comai S, Spadoni G, Bedini A, Rivara S, Fraschini F, Mor M, Tarzia G, Gobbi G. Anxiolytic effects of the melatonin MT(2) receptor partial agonist UCM765: comparison with melatonin and diazepam. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 39: 318-25. PMID 22789661 DOI: 10.1016/J.Pnpbp.2012.07.003  0.765
2012 Morales-Medina JC, Dominguez-Lopez S, Gobbi G, Beck-Sickinger AG, Quirion R. The selective neuropeptide Y Y5 agonist [cPP(1-7),NPY(19-23),Ala31,Aib32,Gln34]hPP differently modulates emotional processes and body weight in the rat. Behavioural Brain Research. 233: 298-304. PMID 22613731 DOI: 10.1016/J.Bbr.2012.05.015  0.372
2012 Bambico FR, Hattan PR, Garant JP, Gobbi G. Effect of delta-9-tetrahydrocannabinol on behavioral despair and on pre- and postsynaptic serotonergic transmission. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 38: 88-96. PMID 22386778 DOI: 10.1016/J.Pnpbp.2012.02.006  0.786
2012 Comai S, Tau M, Pavlovic Z, Gobbi G. The psychopharmacology of aggressive behavior: a translational approach: part 2: clinical studies using atypical antipsychotics, anticonvulsants, and lithium. Journal of Clinical Psychopharmacology. 32: 237-60. PMID 22367663 DOI: 10.1097/Jcp.0B013E31824929D6  0.334
2012 McLaughlin RJ, Hill MN, Bambico FR, Stuhr KL, Gobbi G, Hillard CJ, Gorzalka BB. Prefrontal cortical anandamide signaling coordinates coping responses to stress through a serotonergic pathway. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 664-71. PMID 22325231 DOI: 10.1016/J.Euroneuro.2012.01.004  0.783
2012 Comai S, Tau M, Gobbi G. The psychopharmacology of aggressive behavior: a translational approach: part 1: neurobiology. Journal of Clinical Psychopharmacology. 32: 83-94. PMID 22198449 DOI: 10.1097/Jcp.0B013E31823F8770  0.369
2012 Labonte B, McLaughlin RJ, Dominguez-Lopez S, Bambico FR, Lucchino I, Ochoa-Sanchez R, Leyton M, Gobbi G. Adolescent amphetamine exposure elicits dose-specific effects on monoaminergic neurotransmission and behaviour in adulthood. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 1319-30. PMID 22053980 DOI: 10.1017/S1461145711001544  0.8
2012 McLaughlin RJ, Gobbi G. Cannabinoids and emotionality: a neuroanatomical perspective. Neuroscience. 204: 134-44. PMID 21827834 DOI: 10.1016/J.Neuroscience.2011.07.052  0.652
2012 Domínguez-López S, Mahar I, Bambico FR, Labonté B, Ochoa-Sánchez R, Leyton M, Gobbi G. Short-term effects of melatonin and pinealectomy on serotonergic neuronal activity across the light-dark cycle. Journal of Psychopharmacology (Oxford, England). 26: 830-44. PMID 21730015 DOI: 10.1177/0269881111408460  0.782
2011 Ochoa-Sanchez R, Comai S, Lacoste B, Bambico FR, Dominguez-Lopez S, Spadoni G, Rivara S, Bedini A, Angeloni D, Fraschini F, Mor M, Tarzia G, Descarries L, Gobbi G. Promotion of non-rapid eye movement sleep and activation of reticular thalamic neurons by a novel MT2 melatonin receptor ligand. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 18439-52. PMID 22171046 DOI: 10.1523/Jneurosci.2676-11.2011  0.731
2011 Cassano T, Gaetani S, Macheda T, Laconca L, Romano A, Morgese MG, Cimmino CS, Chiarotti F, Bambico FR, Gobbi G, Cuomo V, Piomelli D. Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice. Psychopharmacology. 214: 465-76. PMID 21042794 DOI: 10.1007/S00213-010-2051-0  0.714
2011 Ochoa-Sanchez R, Comai S, Gobbi G. M-B-035 SLEEP IN MT2 MELATONIN RECEPTOR KNOCKOUT MICE Sleep Medicine. 12: S32. DOI: 10.1016/S1389-9457(11)70113-7  0.307
2010 Bambico FR, Cassano T, Dominguez-Lopez S, Katz N, Walker CD, Piomelli D, Gobbi G. Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 2083-100. PMID 20571484 DOI: 10.1038/Npp.2010.80  0.767
2010 Mazella J, Pétrault O, Lucas G, Deval E, Béraud-Dufour S, Gandin C, El-Yacoubi M, Widmann C, Guyon A, Chevet E, Taouji S, Conductier G, Corinus A, Coppola T, Gobbi G, et al. Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design. Plos Biology. 8: e1000355. PMID 20405001 DOI: 10.1371/Journal.Pbio.1000355  0.438
2010 Bambico FR, Nguyen NT, Katz N, Gobbi G. Chronic exposure to cannabinoids during adolescence but not during adulthood impairs emotional behaviour and monoaminergic neurotransmission. Neurobiology of Disease. 37: 641-55. PMID 19969082 DOI: 10.1016/J.Nbd.2009.11.020  0.743
2009 Hill MN, Hillard CJ, Bambico FR, Patel S, Gorzalka BB, Gobbi G. The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants. Trends in Pharmacological Sciences. 30: 484-93. PMID 19732971 DOI: 10.1016/J.Tips.2009.06.006  0.777
2009 Rivara S, Vacondio F, Fioni A, Silva C, Carmi C, Mor M, Lucini V, Pannacci M, Caronno A, Scaglione F, Gobbi G, Spadoni G, Bedini A, Orlando P, Lucarini S, et al. N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands. Chemmedchem. 4: 1746-55. PMID 19728346 DOI: 10.1002/Cmdc.200900240  0.356
2009 Labonte B, Bambico FR, Gobbi G. Potentiation of excitatory serotonergic responses by MK-801 in the medial prefrontal cortex. Naunyn-Schmiedeberg's Archives of Pharmacology. 380: 383-97. PMID 19727675 DOI: 10.1007/S00210-009-0446-4  0.757
2009 Bambico FR, Duranti A, Tontini A, Tarzia G, Gobbi G. Endocannabinoids in the treatment of mood disorders: evidence from animal models. Current Pharmaceutical Design. 15: 1623-46. PMID 19442178 DOI: 10.2174/138161209788168029  0.766
2009 Blier P, Gobbi G, Turcotte JE, de Montigny C, Boucher N, Hébert C, Debonnel G. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 19: 457-65. PMID 19345072 DOI: 10.1016/J.Euroneuro.2009.01.015  0.507
2009 Cassano T, Gaetani S, Morgese MG, Macheda T, Laconca L, Dipasquale P, Taltavull J, Shippenberg TS, Cuomo V, Gobbi G. Monoaminergic changes in locus coeruleus and dorsal raphe nucleus following noradrenaline depletion. Neurochemical Research. 34: 1417-26. PMID 19229609 DOI: 10.1007/S11064-009-9928-5  0.361
2009 Bambico FR, Nguyen NT, Gobbi G. Decline in serotonergic firing activity and desensitization of 5-HT1A autoreceptors after chronic unpredictable stress. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 19: 215-28. PMID 19147333 DOI: 10.1016/J.Euroneuro.2008.11.005  0.754
2008 Di Marzo V, Gobbi G, Szallasi A. Brain TRPV1: a depressing TR(i)P down memory lane? Trends in Pharmacological Sciences. 29: 594-600. PMID 18947889 DOI: 10.1016/J.Tips.2008.09.004  0.413
2008 Bambico FR, Gobbi G. The cannabinoid CB1 receptor and the endocannabinoid anandamide: possible antidepressant targets. Expert Opinion On Therapeutic Targets. 12: 1347-66. PMID 18851692 DOI: 10.1517/14728222.12.11.1347  0.756
2008 Berney A, Nishikawa M, Benkelfat C, Debonnel G, Gobbi G, Diksic M. An index of 5-HT synthesis changes during early antidepressant treatment: alpha-[11C]methyl-L-tryptophan PET study. Neurochemistry International. 52: 701-8. PMID 17928105 DOI: 10.1016/J.Neuint.2007.08.021  0.426
2007 Rivara S, Lodola A, Mor M, Bedini A, Spadoni G, Lucini V, Pannacci M, Fraschini F, Scaglione F, Sanchez RO, Gobbi G, Tarzia G. N-(substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands. Journal of Medicinal Chemistry. 50: 6618-26. PMID 18052314 DOI: 10.1021/Jm700957J  0.356
2007 Bambico FR, Katz N, Debonnel G, Gobbi G. Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 11700-11. PMID 17959812 DOI: 10.1523/Jneurosci.1636-07.2007  0.785
2007 Gobbi G, Cassano T, Radja F, Morgese MG, Cuomo V, Santarelli L, Hen R, Blier P. Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 17: 328-38. PMID 16950604 DOI: 10.1016/J.Euroneuro.2006.07.004  0.607
2006 Heurteaux C, Lucas G, Guy N, El Yacoubi M, Thümmler S, Peng XD, Noble F, Blondeau N, Widmann C, Borsotto M, Gobbi G, Vaugeois JM, Debonnel G, Lazdunski M. Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype. Nature Neuroscience. 9: 1134-41. PMID 16906152 DOI: 10.1038/Nn1749  0.402
2006 Gobbi G, Janiri L. Sodium- and magnesium-valproate in vivo modulate glutamatergic and GABAergic synapses in the medial prefrontal cortex. Psychopharmacology. 185: 255-62. PMID 16496131 DOI: 10.1007/S00213-006-0317-3  0.378
2005 Gobbi G, Bambico FR, Mangieri R, Bortolato M, Campolongo P, Solinas M, Cassano T, Morgese MG, Debonnel G, Duranti A, Tontini A, Tarzia G, Mor M, Trezza V, Goldberg SR, et al. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proceedings of the National Academy of Sciences of the United States of America. 102: 18620-5. PMID 16352709 DOI: 10.1073/Pnas.0509591102  0.76
2005 Gobbi G. Serotonin firing activity as a marker for mood disorders: lessons from knockout mice. International Review of Neurobiology. 65: 249-72. PMID 16140059 DOI: 10.1016/S0074-7742(04)65009-4  0.476
2005 Gobbi G, Blier P. Effect of neurokinin-1 receptor antagonists on serotoninergic, noradrenergic and hippocampal neurons: comparison with antidepressant drugs. Peptides. 26: 1383-93. PMID 16042978 DOI: 10.1016/J.Peptides.2005.03.032  0.626
2004 Blier P, Gobbi G, Haddjeri N, Santarelli L, Mathew G, Hen R. Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic response. Journal of Psychiatry & Neuroscience : Jpn. 29: 208-18. PMID 15173897  0.591
2003 Gobbi G, Slater S, Boucher N, Debonnel G, Blier P. Neurochemical and psychotropic effects of bupropion in healthy male subjects. Journal of Clinical Psychopharmacology. 23: 233-9. PMID 12826985 DOI: 10.1097/01.Jcp.0000084023.22282.03  0.597
2002 Santarelli L, Gobbi G, Blier P, Hen R. Behavioral and physiologic effects of genetic or pharmacologic inactivation of the substance P receptor (NK1). The Journal of Clinical Psychiatry. 63: 11-7. PMID 12562138  0.547
2001 Gobbi G, Muntoni AL, Gessa GL, Diana M. Clonidine fails to modify dopaminergic neuronal activity during morphine withdrawal. Psychopharmacology. 158: 1-6. PMID 11685378 DOI: 10.1007/S002130100832  0.785
2001 Gobbi G, Murphy DL, Lesch K, Blier P. Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study. The Journal of Pharmacology and Experimental Therapeutics. 296: 987-95. PMID 11181933  0.331
2001 Santarelli L, Gobbi G, Debs PC, Sibille ET, Blier P, Hen R, Heath MJ. Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. Proceedings of the National Academy of Sciences of the United States of America. 98: 1912-7. PMID 11172050 DOI: 10.1073/Pnas.98.4.1912  0.638
2000 Debonnel G, Gobbi G, Turcotte J, Boucher N, Hébert C, De Montigny C, Blier P. Effects of mirtazapine, paroxetine and their combination: a double-blind study in major depression European Neuropsychopharmacology. 10: 252. DOI: 10.1016/S0924-977X(00)80213-8  0.491
1999 Gobbi G, Janiri L. Clozapine blocks dopamine, 5-HT2 and 5-HT3 responses in the medial prefrontal cortex: An in vivo microiontophoretic study European Neuropsychopharmacology. 10: 43-49. PMID 10647096 DOI: 10.1016/S0924-977X(99)00055-3  0.482
1994 Janiri L, Gobbi G, Persico AM, Santarelli M, Minciacchi D, Tempesta E. Alterations of neocortical neuronal responses to acetylcholine and gaba in rats born to alcohol-dependent mothers Alcohol and Alcoholism. 29: 611-619. PMID 7811346 DOI: 10.1093/Oxfordjournals.Alcalc.A045591  0.309
Show low-probability matches.